As of 2026-05-28, the EV/EBITDA ratio of Tandem Diabetes Care Inc (TNDM) is -33.39. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TNDM's latest enterprise value is 1,442.51 mil USD. TNDM's TTM EBITDA according to its financial statements is -43.20 mil USD. Dividing these 2 quantities gives us the above TNDM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.5x - 14.9x | 13.3x |
| Forward P/E multiples | 13.2x - 14.5x | 14.2x |
| Fair Price | (14.54) - (15.37) | (14.91) |
| Upside | -198.1% - -203.7% | -200.6% |
| Date | EV/EBITDA |
| 2026-05-27 | -33.39 |
| 2026-05-26 | -32.95 |
| 2026-05-22 | -33.62 |
| 2026-05-21 | -34.88 |
| 2026-05-20 | -33.74 |
| 2026-05-19 | -31.87 |
| 2026-05-18 | -31.34 |
| 2026-05-15 | -30.22 |
| 2026-05-14 | -32.33 |
| 2026-05-13 | -32.26 |
| 2026-05-12 | -33.18 |
| 2026-05-11 | -33.31 |
| 2026-05-08 | -34.44 |
| 2026-05-07 | -39.18 |
| 2026-05-06 | -38.48 |
| 2026-05-05 | -40.68 |
| 2026-05-04 | -41.40 |
| 2026-05-01 | -40.68 |
| 2026-04-30 | -40.85 |
| 2026-04-29 | -38.68 |
| 2026-04-28 | -39.43 |
| 2026-04-27 | -41.32 |
| 2026-04-24 | -42.17 |
| 2026-04-23 | -42.68 |
| 2026-04-22 | -42.84 |
| 2026-04-21 | -41.65 |
| 2026-04-20 | -43.57 |
| 2026-04-17 | -42.57 |
| 2026-04-16 | -41.74 |
| 2026-04-15 | -42.65 |
| 2026-04-14 | -43.36 |
| 2026-04-13 | -41.76 |
| 2026-04-10 | -40.30 |
| 2026-04-09 | -41.09 |
| 2026-04-08 | -40.57 |
| 2026-04-07 | -38.88 |
| 2026-04-06 | -40.29 |
| 2026-04-02 | -39.40 |
| 2026-04-01 | -39.72 |
| 2026-03-31 | -40.29 |
| 2026-03-30 | -40.94 |
| 2026-03-27 | -43.19 |
| 2026-03-26 | -46.87 |
| 2026-03-25 | -48.36 |
| 2026-03-24 | -48.75 |
| 2026-03-23 | -49.67 |
| 2026-03-20 | -49.24 |
| 2026-03-19 | -48.94 |
| 2026-03-18 | -47.71 |
| 2026-03-17 | -47.80 |